,Group,Gilenya_pat,Gilenya_relapse,Gilenya_relapse_rate,Tecfidera_pat,Tecfidera_relapse,Tecfidera_relapse_rate,actual_treatment,expect_Gilenya_relapse_rate,expect_Tecfidera_relapse_rate,expect_treatment
training,lowest 35%,487,46,0.0944558521560575,450,100,0.222222222222222,-0.127766370066165,0.0855428666439531,0.220365247548517,-0.134822380904564
training,middle 30%,394,24,0.0609137055837563,410,38,0.0926829268292683,-0.0317692212455119,0.0632471016532227,0.0956364249016392,-0.0323893232484166
training,highest 35%,457,84,0.183807439824945,480,50,0.104166666666667,0.0796407731582786,0.180809323657927,0.111879719837413,0.0689296038205144
test,lowest 50%,172,20,0.116279069767442,163,23,0.141104294478528,-0.0248252247110857,0.0749107994433421,0.184592319322266,-0.109681519878924
test,highest 50%,164,23,0.140243902439024,171,20,0.116959064327485,0.023284838111539,0.13844329051989,0.0913880174635276,0.0470552730563622
